Prevalence of vitiligo, impact on quality of life and social stigmatization: results of the first large international survey

T. Passeron, A. Alexis, B. Dreno, L. Wei, A. Morita, C.L. Goh, H.Y. Kang, F. Ly, S. Puig, S. Schalka, J. Ocampo Candiani, A.L. Demessant, C. Le Floc’h, D. Kerob, J. Krutmann, H.W. Lim

  • 10min
  • Oct. 2023
  • Supported by
  • La Roche-Posay
Poster

INTRODUCTION AND OBJECTIVES


Pigmentary disorders (PD) are frequent even if little is known on their real-world prevalence and impact. This first worldwide survey evaluates the self-reported prevalence of PD such as Melasma, Post-inflammatory Hyperpigmentation (PIH), Solar Lentigo, Vitiligo, Peri-Orbital Hyperpigmentation (POH) and Axillary Hyperpigmentation (AH), their impact on quality of life (QOL) and stigmatization. We present here the results of Vitiligo.